Discovery of novel FFA4 (GPR120) receptor agonists with β-arrestin2-biased characteristics.
about
Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development.Application of GPCR Structures for Modelling of Free Fatty Acid Receptors.The acute glucose lowering effect of specific GPR120 activation in mice is mainly driven by glucagon-like peptide 1.Discovery of the First Environment-Sensitive Fluorescent Probe for GPR120 (FFA4) Imaging.Using Biosensors to Study Free Fatty Acid Receptor Pharmacology and Function.
P2860
Discovery of novel FFA4 (GPR120) receptor agonists with β-arrestin2-biased characteristics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Discovery of novel FFA4 (GPR12 ...... estin2-biased characteristics.
@ast
Discovery of novel FFA4 (GPR12 ...... estin2-biased characteristics.
@en
type
label
Discovery of novel FFA4 (GPR12 ...... estin2-biased characteristics.
@ast
Discovery of novel FFA4 (GPR12 ...... estin2-biased characteristics.
@en
prefLabel
Discovery of novel FFA4 (GPR12 ...... estin2-biased characteristics.
@ast
Discovery of novel FFA4 (GPR12 ...... estin2-biased characteristics.
@en
P2093
P2860
P356
P1476
Discovery of novel FFA4 (GPR12 ...... restin2-biased characteristics
@en
P2093
Duxiao Yang
Jinpeng Sun
Kun-hong Xiao
Mengyuan Zhu
P2860
P304
P356
10.4155/FMC.15.160
P577
2015-12-14T00:00:00Z